FDA Approves Zanvastro as First Alexander Disease Drug
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has approved Zanvastro (zilganersen) injection...
Biopharmaceutical Development
Advertisement
Cipla Partners with Qilu on Keytruda Biosimilar
Mumbai, India and Warren, New Jersey, USA, September 3, 2026 Cipla Limited, through its wholly owned subsidiary InvaGen Pharmaceuticals...
VectorBuilder and Lir Advance AI-Driven AAV Capsids
Chicago, Illinois, August 18, 2026 VectorBuilder and Lir Therapeutics have announced a strategic collaboration to advance adeno-associated virus (AAV)...
ArkBio Advances Ziresovir in FDA-Approved Phase II RSV Trial
Shanghai, China, August 14, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that the U.S. Food and Drug Administration...
Egg Medical Gains Patent Advantage After Rampart Appeal Ends
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
Advertisements
Dark Horse Consulting Expands China Cell Therapy Practice
WALNUT CREEK, California & SHANGHAI, China, August 11, 2026 Dark Horse Consulting Group (DHCG), a life sciences consulting organization...
Waters Launches New Platform for GLP-1 and LNP Analytics
MILFORD, Massachusetts, USA – June 8, 2026 Waters Corporation has introduced its BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and...
Advertisement
